Investigating Serum Prolactin Levels in Metabolic Syndrome and Their Association with Insulin Resistance
Objective: To explore the association between serum prolactin levels and insulin resistance markers in metabolic syndrome patients, providing potential insights for targeted therapeutic interventions. Methodology: Through the use of a cross-sectional methodology, the purpose of this study was to investigate the possibility of a connection between insulin resistance and blood prolactin levels. Participants in this study were comprised of adults who had been diagnosed with metabolic syndrome. Individuals were recruited from the outpatient clinics of the nearby hospitals. People ranging in age from thirty to sixty years old were included in the study. There was a significant age gap between them. Serum prolactin levels, insulin resistance indicators (such as the HOMA-IR), and fasting glucose levels were some of the studied metabolic markers. Other metabolic markers included lipid profiles. Specific metabolic markers, such as those listed below, were among those that were investigated. Result: The findings indicate that there is a significant positive link between the levels of serum prolactin and insulin resistance measures such as HOMA-IR, fasting glucose, and triglyceride levels. The findings indicate that there is an inverse relationship between the levels of prolactin and HDL cholesterol. Because greater prolactin levels were also related with obesity and inflammatory markers, it is probable that they contribute to the worsening of metabolic dysregulation. This is because of the presence of both factors. Based on these findings, it seems that elevated levels of prolactin in the blood may be a significant endocrine component that contributes to insulin resistance in metabolic syndrome. Conclusion: Patients with metabolic syndrome who have increased prolactin levels also have insulin resistance, according to the findings of this research, which give significant support to this assertion. As a result of its impact on inflammation, lipid metabolism, and obesity, prolactin may have a substantial role in the development of metabolic syndrome. It is necessary to do further research, especially longitudinal studies, to understand the nature of this connection better and ascertain whether prolactin might be an effective therapeutic target for treating insulin resistance in metabolic syndrome.